Literature DB >> 23778654

Occult hepatitis B virus infection among injecting drug users in the Central-West Region of Brazil.

Márcia Alves Dias de Matos1, Renata Carneiro Ferreira, Fabiana Perez Rodrigues, Tamíris Augusto Marinho, Carmen Luci Rodrigues Lopes, Antônia Carlos Magalhães Novais, Ana Rita Coimbra Motta-Castro, Sheila Araújo Teles, Francisco José Dutra Souto, Regina Maria Bringel Martins.   

Abstract

The prevalence of occult hepatitis B virus (HBV) infection was investigated in 149 hepatitis B surface antigen (HBsAg) negative injecting drug users (IDUs) in the Central-West Region of Brazil. Of these individuals, 19 were positive for HBV DNA, resulting in an occult HBV infection prevalence of 12.7% (19/149); six of these 19 individuals had anti-HBV core and/or anti-HBV surface antibodies and 13 were negative for HBV markers. All IDUs with occult hepatitis B reported sexual and/or parenteral risk behaviours. All HBV DNA-positive samples were successfully genotyped. Genotype D was the most common (17/19), followed by genotype A (2/19). These findings reveal a high prevalence of occult HBV infection and the predominance of genotype D among IDUs in Brazil's Central-West Region.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23778654      PMCID: PMC4005573          DOI: 10.1590/S0074-02762013000300019

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  27 in total

Review 1.  Occult hepatitis B virus infection.

Authors:  Giovanni Raimondo; Teresa Pollicino; Irene Cacciola; Giovanni Squadrito
Journal:  J Hepatol       Date:  2006-11-07       Impact factor: 25.083

2.  Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA.

Authors:  P D Swenson; C Van Geyt; E R Alexander; H Hagan; J M Freitag-Koontz; S Wilson; H Norder; L O Magnius; L Stuyver
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

Review 3.  Epidemiology and prevention of hepatitis B.

Authors:  Miriam J Alter
Journal:  Semin Liver Dis       Date:  2003-02       Impact factor: 6.115

Review 4.  An overview of occult hepatitis B virus infection.

Authors:  Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

5.  Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.

Authors:  Renata C Ferreira; Fabiana P Rodrigues; Sheila A Teles; Carmen L R Lopes; Ana Rita C Motta-Castro; Antônia C M Novais; Francisco J D Souto; Regina M B Martins
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

6.  High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users.

Authors:  Chih-Lin Lin; Chun-Jen Liu; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen; Jia-Horng Kao
Journal:  J Med Virol       Date:  2007-11       Impact factor: 2.327

7.  Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia.

Authors:  Alhusain J Alzahrani; Damian M Dela Cruz; Obeid E Obeid; Huda A Bukhari; Ahmed A Al-Qahtani; Mohammed N Al-Ahdal
Journal:  J Med Virol       Date:  2009-08       Impact factor: 2.327

Review 8.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

9.  Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates.

Authors:  Francisco C A Mello; Francisco J D Souto; Leticia C Nabuco; Cristiane A Villela-Nogueira; Henrique Sergio M Coelho; Helena Cristina F Franz; Joao Carlos P Saraiva; Helaine A Virgolino; Ana Rita C Motta-Castro; Mabel M M Melo; Regina M B Martins; Selma A Gomes
Journal:  BMC Microbiol       Date:  2007-11-23       Impact factor: 3.605

10.  Common genotypes of Hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan.

Authors:  Muhammad Masroor Alam; Sohail Zahoor Zaidi; Shehzad Shaukat; Salmaan Sharif; Mehar Angez; Asif Naeem; Shamim Saleha; Javed Aslam Butt; Salman Akbar Malik
Journal:  Virol J       Date:  2007-06-28       Impact factor: 4.099

View more
  5 in total

1.  Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study.

Authors:  Elisabeth Lampe; Francisco C A Mello; Marcia P do Espírito-Santo; Cintia M C Oliveira; Dennis A Bertolini; Neiva S L Gonçales; Regina C Moreira; Carlos A S Fernandes; Haydée C L Nascimento; Rejane M T Grotto; Maria Inês M C Pardini
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

2.  Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.

Authors:  Ricardo Wagner de Almeida; Francisco Campello do Amaral Mello; Isabelle Vasconcelos Menegoy; Márcia Paschoal do Espírito Santo; Cléber Ferreira Ginuíno; Paulo Sérgio Fonseca de Sousa; Livia Melo Villar; Elisabeth Lampe; Lia Laura Lewis-Ximenez
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-07       Impact factor: 2.743

3.  Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factors in the North, South, and Southeast Regions of Brazil, 10-20 Years After the Beginning of Vaccination.

Authors:  Ricardo A A Ximenes; Gerusa M Figueiredo; Maria Regina A Cardoso; Airton T Stein; Regina C Moreira; Gabriela Coral; Deborah Crespo; Alex A Dos Santos; Ulisses R Montarroyos; Maria Cynthia Braga; Leila M M B Pereira
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

4.  Risk factors for hepatitis B transmission in South Brazil.

Authors:  Vagner Reinaldo Zingalli Bueno Pereira; Jonas Michel Wolf; Camila Albani da Silva Luz; Gláucia Zuleide Stumm; Thais da Rocha Boeira; Josiane Galvan; Daniel Simon; Vagner Ricardo Lunge
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-08       Impact factor: 2.743

5.  Seroprevalence of Hepatitis B Infection and Associated Risk Factors among Drug Users in Drop-in Centers of Isfahan, Iran.

Authors:  Roya Taleban; Mohammad Moafi; Behrooz Ataei; Majid Yaran; Zary Nokhodian; Nazila Kassaian; Peyman Adibi; Abbasali Javadi
Journal:  Int J Prev Med       Date:  2018-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.